Allergan Aesthetics, an AbbVie (ABBV) company, announced that the U.S. FDA accepted for review the supplemental premarket approval application for SKINVIVE by JUVEDERM to reduce neck lines for the improvement of neck appearance. SKINVIVE by JUVEDERM is currently approved in the U.S. to improve skin smoothness of the cheeks in adults over the age of 21.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.